Timothy Enns

Mr. Enns is President and Chief Executive Officer of NanoValent. Mr. Enns has over 30 years experience in leadership roles within Pharmaceutical and Biotechnology companies. Prior to NanoValent he held senior executive roles at KineMed Inc, Astex Pharmaceuticals, Inc (now Otsuka) and Sequus Pharmaceuticals. Mr. Enns management roles have included Business Development, Corporate Communications and Investor Relations, Marketing and Sales. His prior experience includes most aspects of cancer therapeutic commercialization from start up through launch and partnering. Prior to Sequus he held senior positions at Trilex, Syncor, MGI Pharma, Adria Labs and Upjohn. He has a BS in Nutritional Science & Biochemistry from UC Davis.